Sign In
Buy PFE
$26.04
+0.350 (+1.36%)
At Close: Jun 05, 2026
Pfizer Q1 earnings: non-Covid product sales help post revenues of $14.9 billion despite Comirnaty, Paxlovid decline
07:01am, Wednesday, 01'st May 2024
Pfizer Inc. (NYSE: PFE) has announced its financial outcomes for the first quarter of 2024, displaying strong performance in its non-COVID product portfolio. This includes heightened revenues from rec
Pfizer beats profit estimates on cost cuts, RSV vaccine sales
06:50am, Wednesday, 01'st May 2024
Pfizer beat first-quarter profit estimates on Wednesday, benefiting from cost cuts and strong sales for its pneumonia and respiratory synctitial virus vaccines.
7 Safe Haven Stocks That Can Withstand the Market's Worst Meltdowns
01:50pm, Tuesday, 30'th Apr 2024
Everyone needs solace in stability and development in the current turbulent market climate. These are seven unwavering businesses that are well-known for their fundamental capability to withstand mark
Will These 5 Drug/Biotech Stocks Beat Q1 Earnings Forecast?
12:21pm, Tuesday, 30'th Apr 2024
Let's look at five large-cap pharma/biotech companies slated to release quarterly results this week.
5 Top Stocks to Buy in May
07:45am, Tuesday, 30'th Apr 2024
Microsoft's growth backs up the stock's premium valuation. Pfizer, NextEra Energy, and Home Depot are industry-leading businesses with quality dividends.
Why I'm Buying This Beaten-Down, High-Yield Dividend Stock Hand Over Fist
05:50am, Tuesday, 30'th Apr 2024
Pfizer faces challenges with declining COVID-19 product sales and upcoming patent expirations for key products. However, the company's valuation, dividend yield, and overall growth prospects remain at
Forget Nvidia: Prominent Billionaires Are Selling It and Buying These 2 Ultra-High-Yield Dividend Stocks Instead
05:06am, Tuesday, 30'th Apr 2024
The rise of artificial intelligence (AI) has most of Wall Street seeing big dollar signs. Despite Nvidia's phenomenal growth, three top-tier billionaire investors each sold more than 1 million shares
Pfizer, Genmab get full FDA approval for cervical-cancer drug
06:58pm, Monday, 29'th Apr 2024
Pfizer and Genmab on Monday said they had received full approval from U.S. regulators for their treatment for certain forms of cervical cancer.
Here's How to Play Pfizer (PFE) Stock Ahead of Q1 Earnings
01:16pm, Monday, 29'th Apr 2024
Pfizer (PFE) expects its operational revenues to improve, driven by its in-line products like Vyndaqel, new launches like Abrysvo and newly acquired products, including those acquired from Seagen.
Why Pfizer (PFE) is a Top Value Stock for the Long-Term
10:46am, Monday, 29'th Apr 2024
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
The most jam-packed earnings week for the quarter lies ahead, led by these two market bellwethers
10:01am, Sunday, 28'th Apr 2024
This week, 175 companies in the S&P 500 index report quarterly results, making it the busiest for the U.S. earnings reporting season overall. But amid the stampede, much of Wall Street's attention wil
5 Of The Highest Yielding Blue Chip Stocks To Buy Now
07:45am, Sunday, 28'th Apr 2024
Smart Investors Are Quietly Loading Up on These “Dividend Legends” (Sponsored) If you want your portfolio to pay you cash like clockwork, it's time to stop blindly following conventional wisdom li
3 High-Yield Dividend Stocks That Could Soar 22% to 49%, According to Wall Street
05:50am, Sunday, 28'th Apr 2024
Pfizer has better prospects than meet the eye. Brookfield Infrastructure's asset rotation strategy should drive growth and higher distributions.
3 Dividend Stocks to Buy and Hold for the Next Decade
07:15am, Saturday, 27'th Apr 2024
AbbVie is an unstoppable passive income machine. Eli Lilly offers a sizzling stock performance and a growing dividend.
7 Dividend Stocks to Buy Now for Steady Returns in Any Market
06:00am, Saturday, 27'th Apr 2024
Dividend stocks can be a great way to build wealth. If you are a long-term investor and believe in dividend reinvesting, you could generate above-average returns over a few years.
